Toronto, February 7, 2018: Cornerstone Research Group and MORSE Consulting are pleased to announce the creation of a strategic partnership between our two organizations. This strategic partnership will simplify the logistical process for our clients utilizing our combined services when shepherding a product from reimbursement strategy, to CADTH submission and finally to pCPA negotiations. Together the collaboration between Cornerstone and MORSE offers clients a breadth of reimbursement consulting services…
Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc. is pleased to introduce MORSE WIRE, a new feature on our website. MORSE WIRE is a newsfeed that provides real time, useful market access information to help stakeholders stay informed of the latest developments in the Canadian pharmaceutical reimbursement environment. MORSE WIRE has a user-friendly interface with 5 broad categories to allow users to sort and search based on keywords. The…
Changes, Updates and Reminders Related to CDR Guidelines On Friday, June 9th, CADTH issued a CDR Update with a number of changes, updates, and reminders that are worth reviewing. The key highlights are: Two Process Changes Guidance for Subsequent Entry Non-Biological Complex Drugs Revised Documentation for Resubmissions Two Reminders (In-person CDR Meetings/Confidential Prices) Communication with Consultants Further detail, which has been drawn from the CDR Update, can be found…
CAPCA has initiated consultations with stakeholders on its recent initiative aimed at addressing the challenges facing the oncology drug system. The Canadian Association of Provincial Cancer Agencies (CAPCA) recently held its first set of round-table sessions (Vancouver and Toronto) with pharmaceutical industry representatives and patient groups to discuss the pan-Canadian Cancer Drug Funding Sustainability (DFS) Initiative. This initiative was initially introduced via webinars in January and February 2017 and…